Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 333

The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.

Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response

Brines, M., Cerami, A.·2008·Journal of Internal Medicine

Abstract

Abstract.: In its classic hormonal role, erythropoietin (EPO) is produced by the kidney and regulates the number of erythrocytes within the circulation to provide adequate tissue oxygenation. EPO also mediates other effects directed towards optimizing oxygen delivery to tissues, e.g. modulating regional blood flow and reducing blood loss by promoting thrombosis within damaged vessels. Over the past 15 years, many unexpected nonhaematopoietic functions of EPO have been identified. In these more recently appreciated nonhormonal roles, locally‐produced EPO signals through a different receptor isoform and is a major molecular component of the injury response, in which it counteracts the effects of pro‐inflammatory cytokines. Acutely, EPO prevents programmed cell death and reduces the development of secondary, pro‐inflammatory cytokine‐induced injury. Within a longer time frame, EPO provides trophic support to enable regeneration and healing. As the region immediately surrounding damage is typically relatively deficient in endogenous EPO, administration of recombinant EPO can provide increased tissue protection. However, effective use of EPO as therapy for tissue injury requires higher doses than for haematopoiesis, potentially triggering serious adverse effects. The identification of a tissue‐protective receptor isoform has facilitated the engineering of nonhaematopoietic, tissue‐protective EPO derivatives, e.g. carbamyl EPO, that avoid these complications. Recently, regions within the EPO molecule mediating tissue protection have been identified and this has enabled the development of potent tissue‐protective peptides, including some mimicking EPO’s tertiary structure but unrelated in primary sequence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2796.2008.02024.x

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 186 references

Cited by

See all 333

Metadata

Authors
Brines, M., & Cerami, A.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2008-10-08
Volume
264
Issue
5
Pages
405-432
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2110788486
Cited by
333
References
186
FWCI
13.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response. https://app.cochat.ai/papers/10.1111/j.1365-2796.2008.02024.x
The paper
Brines, M., & Cerami, A. (2008). Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.2008.02024.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.